Day: October 6, 2018

How Dr. Martens Used Lytics CDP to Achieve a 60 Percent Higher Conversion Rate

From Startup Lytics Link to Full Article: https://www.lytics.com/blog/how-dr-martens-used-lytics-cdp-to-achieve-a-60-percent-higher-conversion-rate Dr. Martens achieved incredible results with data-driven, customer-centric, targeted marketing. Here’s how. When iconic shoe brand Dr. Martens decided to use Lytics Customer Data Platform (CDP) to unify, collect and segment their customer data, the results were powerful. In fact, one targeted

Eidos Therapeutics to Present Phase 2 Data for AG10 in TTR Amyloidosis Cardiomyopathy at the AHA 2018 Scientific Sessions in a Late-Breaking Featured Science Oral Presentation

From Startup Eidos Therapeutics Link to Full Article: http://ir.eidostx.com/news-releases/news-release-details/eidos-therapeutics-present-phase-2-data-ag10-ttr-amyloidosis SAN FRANCISCO, Oct. 05, 2018 (GLOBE NEWSWIRE) — Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), today announced that results of its Phase 2 clinical trial studying AG10 in subjects with symptomatic transthyretin (TTR) amyloidosis cardiomyopathy (ATTR-CM) will be announced in a late-breaking featured